At Home Cancer Testing Market
Informe de investigación de mercado de Pruebas de cáncer en el hogar por tipo de prueba (pruebas genéticas, pruebas de biomarcadores, pruebas inmunológicas, pruebas de ADN libre de células), por tipo de muestra (muestra de sangre, muestra de saliva, muestra de orina, muestra de tejido), por canal de distribución (farmacias en línea, farmacias minoristas, directo al consumidor), por usuario final (individuos, profesionales de la salud, instituciones de investigación) y por región (América del Norte, Europa, América del Sur, Asia Pacífico, Med... leer más
Las empresas clave en el mercado At Home Cancer Testing Market incluyen
Alcance del informe
FAQs
What is the current valuation of the At-Home Cancer Testing Market?
The At-Home Cancer Testing Market was valued at 3.74 USD Billion in 2024.
What is the projected market size for the At-Home Cancer Testing Market by 2035?
The market is projected to reach 19.91 USD Billion by 2035.
What is the expected CAGR for the At-Home Cancer Testing Market during the forecast period?
The expected CAGR for the market from 2025 to 2035 is 16.42%.
Which companies are considered key players in the At-Home Cancer Testing Market?
Key players include Exact Sciences, GRAIL, Guardant Health, Foundation Medicine, Caris Life Sciences, OncoOne, Biocept, and NantHealth.
What are the main types of testing in the At-Home Cancer Testing Market?
The main types of testing include Genetic Testing, Biomarker Testing, Immunological Testing, and Cell-free DNA Testing.
How does the market segment by sample type?
The market segments by sample type include Blood Sample, Saliva Sample, Urine Sample, and Tissue Sample.
What distribution channels are utilized in the At-Home Cancer Testing Market?
Distribution channels include Online Pharmacies, Retail Pharmacies, and Direct-to-Consumer sales.
Who are the primary end users of At-Home Cancer Testing products?
Primary end users consist of Individuals, Healthcare Professionals, and Research Institutions.
What was the market valuation for Genetic Testing in 2024?
In 2024, the market valuation for Genetic Testing was 0.74 USD Billion.
What is the projected valuation for Biomarker Testing by 2035?
Biomarker Testing is projected to reach 5.83 USD Billion by 2035.
Complete el formulario a continuación para recibir una muestra gratuita de este informe
Customer Stories
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
“Thank you, this will be very helpful for OQS.”
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”
Deja un comentario